VANCOUVER, B.C., May 1, 2002 (PRIMEZONE) -- Pyng Medical Corp. (subsidiary of Pyng Technologies) (OTCBB:PYNGF) (CDNX:PYT) is pleased to provide the following update on the F.A.S.T.1 System for Adult Intraosseous Infusion.
Pyng Medical Corp. executives were invited to attend a special meeting April 25th, 2002 at Fort Sam Houston, San Antonio, Texas to meet senior staff members and consultants to the US Army Medical Department Center and School, the Directorate of Combat and Doctrine Development (AMEDD). The sole purpose of the meeting was the F.A.S.T.1 System for Adult Intraosseous Infusion.
Michael W. Jacobs, Chairman/Founder, David L. Johnson, President, and Judy Findlay, CEO of Pyng Medical Corp., made the presentation on the F.A.S.T.1 System to AMEDD.
Pyng Medical has addressed the need for a faster, more reliable vascular access route, usable in emergency environments. With the F.A.S.T.1 System, vascular access in adults can be reliably, effectively, and safely achieved in 60 seconds or less in pre-hospital emergency or battlefield environments.
Pyng Medical Corp. has already delivered, as announced in previous news releases, F.A.S.T.1 Systems to the US Army Special Forces Rangers and Airborne.
For further information contact 1-800-349-7964 or visit our website at www.pyng.com
On Behalf of the Board of Directors,
Michael W. Jacobs, Chairman.
The Canadian Venture Exchange has neither reviewed nor approved of the contents of this news release.
Safe Harbor Statement: This release may contain certain forward-looking statements including without limitation, projections, assumptions, expectations, product development objectives, commercial introduction, and potential advantages of the F.A.S.T.1 System. Actual events or results may differ from the Company's expectations as a result of risk factors discussed in Pyng Technologies Corp. reports on the file with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's report on Form 20F for the year ended September 30, 2001.